Novo Nordisk has provided updates on its insulin and GLP-1 product lines. Following a previous announcement of price reductions, the company has discontinued the basal insulin Levemir.
Results for: Insulin
Novo Nordisk’s decision to discontinue Levemir insulin has sparked concerns among Democratic senators. Despite initial praise for Novo’s acquisition of up to 75% of the insulin market, the discontinuation has led to supply disruptions and insurance cutoffs, leaving patients with limited options.
Delhi Chief Minister Arvind Kejriwal was denied his request for insulin in Tihar Jail by a special court but later received a “light dose” after consultation with AIIMS doctors. The decision sparked allegations of conspiracy from the Aam Aadmi Party (AAP), who claimed the court’s decision was politically motivated. Jail authorities clarified that the insulin was administered after Kejriwal’s blood sugar levels spiked, as per the recommendation of an AIIMS specialist. The incident has sparked debate and political controversy, with AAP functionaries and Kejriwal’s wife attributing his insulin administration to the blessings of Lord Hanuman on Hanuman Jayanti. Meanwhile, jail authorities maintain that all inmates, including Kejriwal, receive equal treatment for medical needs.
Amidst the ongoing controversy over Arvind Kejriwal’s blood sugar levels, the Tihar Jail administration has finally administered insulin to the jailed Delhi Chief Minister. This development comes after Kejriwal had repeatedly requested insulin for his increasing sugar levels. Senior AAP functionaries have welcomed the move but have also criticized the jail administration for not providing insulin earlier.
Delhi Chief Minister Arvind Kejriwal has been given a ‘low dose’ of insulin after his blood sugar level spiked, according to Tihar jail officials. Kejriwal was given the insulin on the advice of AIIMS doctors after his blood sugar level was found to be 217 around 7 p.m. on Monday. AAP sources said Kejriwal’s blood sugar level had crossed 320 in Tihar, and this is the first time he has been given insulin in jail.
Amidst allegations and counterclaims, Delhi Chief Minister Arvind Kejriwal’s access to insulin has become a contentious issue. Here’s a breakdown of the significance of insulin for diabetics, its appropriate use, and the potential consequences of discontinuing it.
Delhi Chief Minister Arvind Kejriwal, who is currently under judicial custody at Tihar Jail, has been given insulin after his sugar level surged to 320. This is the first insulin dosage administered to Kejriwal after his arrest by the Enforcement Directorate on March 21 in connection to a money laundering case linked to the Delhi liquor policy case. The Delhi Chief Minister will remain in judicial custody until the next hearing on April 23.
Delhi Chief Minister Arvind Kejriwal received his first insulin dose in Tihar Jail on Tuesday after his blood sugar levels spiked to 320. The decision was made after his sugar levels consistently increased since his arrest on March 21st. Despite requests, Kejriwal had previously accused prison authorities of denying him insulin. The court directed AIIMS to form a medical board to assess Kejriwal’s medical needs, specifically regarding insulin. Jail authorities maintain that Kejriwal’s health is being monitored and that he is no longer denied insulin.
Delhi Chief Minister Arvind Kejriwal has received insulin treatment in Tihar Jail following elevated blood sugar levels. The insulin administration marks the first time Kejriwal has undergone such treatment since his arrest by the Enforcement Directorate (ED).
Governor Kathy Hochul has signed legislation to eliminate insulin cost-sharing for New Yorkers with state-regulated health insurance plans, saving an estimated $14 million in 2025 alone. The budget also includes a $37 billion Medicaid investment plan, support for pregnant mothers, and protections against medical debt lawsuits for low-income individuals.